FMT

FMT

2939 bookmarks
Custom sorting
Successful Treatment of pMMR MSS IVB Colorectal Cancer Using Anti-VEGF and Anti-PD-1 Therapy in Combination of Gut Microbiota Transplantation: A Case Report
Successful Treatment of pMMR MSS IVB Colorectal Cancer Using Anti-VEGF and Anti-PD-1 Therapy in Combination of Gut Microbiota Transplantation: A Case Report
Immune checkpoint inhibitors (ICI) have shown great promise in treating advanced or metastatic colorectal cancer (mCRC), especially for CRC patients with deficient mismatch repair (dMMR) and high microsatellite instability (MSI-H). For the remainder of CRC patients presenting with proficient mismatch repair (pMMR) and microsatellite stable (MSS) or low microsatellite instability (MSI-L), ICI showed a low-level response. This study describes a 57-year-old Chinese man diagnosed with pMMR MSS IVb CRC with liver metastasis. Primarily, the patient was administered two consecutive treatments, one composed of an anti-EGFR and modified FOLFOX6 and the other composed of an anti-VEGF and FOLFOXIRI. Due to severe chemotherapy side effects, the patient discontinued treatment and decided to take a third investigational treatment, where an anti-PD-1 and an anti-VEGF were given in combination with fecal microbiota transplantation (FMT) capsules. The patient achieved a partial response (PR), and the tumor size decreased to the extent amenable to surgical resection. After surgery, the patient achieved a pathological complete response (pCR). Patients with pMMR MSS or MSI-L hardly benefit from anti-PD-1 immunotherapy. This study indicated that, to a limited extent, FMT might improve the response to ICI for pMMR MSS CRC patients.
·cureus.com·
Successful Treatment of pMMR MSS IVB Colorectal Cancer Using Anti-VEGF and Anti-PD-1 Therapy in Combination of Gut Microbiota Transplantation: A Case Report
The potential role of the microbiota in prostate cancer pathogenesis and treatment - PubMed
The potential role of the microbiota in prostate cancer pathogenesis and treatment - PubMed
The human body hosts a complex and dynamic population of trillions of microorganisms - the microbiota - which influences the body in homeostasis and disease, including cancer. Several epidemiological studies have associated specific urinary and gut microbial species with increased risk of prostate c …
·pubmed.ncbi.nlm.nih.gov·
The potential role of the microbiota in prostate cancer pathogenesis and treatment - PubMed
Faecal microbiota transplantation (FMT) in the treatment of chronic refractory pouchitis: A systematic review and meta-analysis | Journal of Crohn's and Colitis | Oxford Academic
Faecal microbiota transplantation (FMT) in the treatment of chronic refractory pouchitis: A systematic review and meta-analysis | Journal of Crohn's and Colitis | Oxford Academic
AbstractBackground. The aim of this systematic review and meta-analysis is to assess the efficacy and safety of faecal microbiota transplantation (FMT) in the t
·academic.oup.com·
Faecal microbiota transplantation (FMT) in the treatment of chronic refractory pouchitis: A systematic review and meta-analysis | Journal of Crohn's and Colitis | Oxford Academic
Short-chain fatty and carboxylic acid changes associated with fecal microbiota transplant communally influence microglial inflammation - PubMed
Short-chain fatty and carboxylic acid changes associated with fecal microbiota transplant communally influence microglial inflammation - PubMed
The intestinal microbiota has been proposed to influence human mental health and cognition through the gut-brain axis. Individuals experiencing recurrent Clostridioides difficile infection (rCDI) frequently report depressive symptoms, which are improved after fecal microbiota transplantation …
·pubmed.ncbi.nlm.nih.gov·
Short-chain fatty and carboxylic acid changes associated with fecal microbiota transplant communally influence microglial inflammation - PubMed
Short-chain fatty and carboxylic acid changes associated with fecal microbiota transplant communally influence microglial inflammation - PubMed
Short-chain fatty and carboxylic acid changes associated with fecal microbiota transplant communally influence microglial inflammation - PubMed
The intestinal microbiota has been proposed to influence human mental health and cognition through the gut-brain axis. Individuals experiencing recurrent Clostridioides difficile infection (rCDI) frequently report depressive symptoms, which are improved after fecal microbiota transplantation …
·pubmed.ncbi.nlm.nih.gov·
Short-chain fatty and carboxylic acid changes associated with fecal microbiota transplant communally influence microglial inflammation - PubMed
Colorectal cancer and gut microbiota studies in China - PubMed
Colorectal cancer and gut microbiota studies in China - PubMed
Colorectal cancer (CRC) is the third most common malignant tumor worldwide. The incidence and mortality rates of CRC have been increasing in China, possibly due to economic development, lifestyle, and dietary changes. Evidence suggests that gut microbiota plays an essential role in the tumorigenesis …
·pubmed.ncbi.nlm.nih.gov·
Colorectal cancer and gut microbiota studies in China - PubMed
Implementation of routine Clostridioides difficile infection (CDI) primary prophylaxis in lung transplant recipients - PubMed
Implementation of routine Clostridioides difficile infection (CDI) primary prophylaxis in lung transplant recipients - PubMed
Lung transplant recipients are at an increased risk for Clostridioides difficile infection (CDI), and those who develop CDI post-transplant can have worsened outcomes including graft failure and death. We sought to describe the efficacy and safety of primary CDI prophylaxis with oral vancomycin amon …
·pubmed.ncbi.nlm.nih.gov·
Implementation of routine Clostridioides difficile infection (CDI) primary prophylaxis in lung transplant recipients - PubMed
Fecal virome transplantation is sufficient to alter fecal microbiota and drive lean and obese body phenotypes in mice - PubMed
Fecal virome transplantation is sufficient to alter fecal microbiota and drive lean and obese body phenotypes in mice - PubMed
The gastrointestinal microbiome plays a significant role in modulating numerous host processes, including metabolism. Prior studies show that when mice receive fecal transplants from obese donors on high-fat diets (HFD) (even when recipient mice are fed normal diets after transplantation), they deve …
·pubmed.ncbi.nlm.nih.gov·
Fecal virome transplantation is sufficient to alter fecal microbiota and drive lean and obese body phenotypes in mice - PubMed
Microbiota from healthy mice alleviates cognitive decline via reshaping the gut-brain metabolic axis in diabetic mice - PubMed
Microbiota from healthy mice alleviates cognitive decline via reshaping the gut-brain metabolic axis in diabetic mice - PubMed
Diabetic cognitive decline has been associated with the gut microbial disorders, but its potential gut-brain axis mechanisms remain unclear. Herein we transplanted the gut microbiota from healthy mice into type 1 diabetic (T1D) mice and then investigated the effect of fecal microbiota transplantatio …
·pubmed.ncbi.nlm.nih.gov·
Microbiota from healthy mice alleviates cognitive decline via reshaping the gut-brain metabolic axis in diabetic mice - PubMed
High carriage rate of extended-spectrum β-lactamase Enterobacterales and diarrheagenic Escherichia coli in healthy donor screening for fecal microbiota transplantation - PubMed
High carriage rate of extended-spectrum β-lactamase Enterobacterales and diarrheagenic Escherichia coli in healthy donor screening for fecal microbiota transplantation - PubMed
The safety of fecal microbiota transplantation (FMT) has been highlighted by extended-spectrum β-lactamase (ESBL)-producing Escherichia coli bacteremia transmitted from donors and acquisition of diarrheagenic E. coli (Shiga toxin-producing E. coli (STEC) and enteropathogenic E. coli (EPEC)) via FMT. …
·pubmed.ncbi.nlm.nih.gov·
High carriage rate of extended-spectrum β-lactamase Enterobacterales and diarrheagenic Escherichia coli in healthy donor screening for fecal microbiota transplantation - PubMed
Histamine-producing bacteria and their role in gastrointestinal disorders
Histamine-producing bacteria and their role in gastrointestinal disorders
Gut microbiota produces thousands of metabolites, which have a huge impact on the host health. Specific microbial strains are able to synthesize histamine, a molecule with a crucial role in many ph...
·tandfonline.com·
Histamine-producing bacteria and their role in gastrointestinal disorders
Effects of fecal microbiota transplantation in metabolic syndrome: A meta-analysis of randomized controlled trials - PubMed
Effects of fecal microbiota transplantation in metabolic syndrome: A meta-analysis of randomized controlled trials - PubMed
FMT, as an adjunctive therapy, does not produce any serious adverse effects and may be useful in the treatment of metabolic syndrome, especially in improving HbA1c, insulin sensitivity, and HDL cholesterol. However, there was no significant difference between the FMT group and the placebo group in t …
·pubmed.ncbi.nlm.nih.gov·
Effects of fecal microbiota transplantation in metabolic syndrome: A meta-analysis of randomized controlled trials - PubMed
Radiation injury and gut microbiota-based treatment - PubMed
Radiation injury and gut microbiota-based treatment - PubMed
The exposure to either medical sources or accidental radiation can cause varying degrees of radiation injury (RI). RI is a common disease involving multiple human body parts and•organs, yet effective treatments are currently limited. Accumulating evidence suggests gut microbiota are closely associat …
·pubmed.ncbi.nlm.nih.gov·
Radiation injury and gut microbiota-based treatment - PubMed
GutMicrobiota Health on Twitter
GutMicrobiota Health on Twitter
Why taking care of our microbiome is essential for planetary health?.@dorejoel discussed the importance of the microbiome for better human and planet well-being in this @TEDxAPT's talk:https://t.co/FbukdWqLyC— GutMicrobiota Health (@GMFHx) July 20, 2023
·twitter.com·
GutMicrobiota Health on Twitter
Depletion of butyrate-producing microbes of the Firmicutes predicts nonresponse to FMT therapy in patients with recurrent Clostridium difficile infection - PubMed
Depletion of butyrate-producing microbes of the Firmicutes predicts nonresponse to FMT therapy in patients with recurrent Clostridium difficile infection - PubMed
Approximately 10% of individuals diagnosed with Clostridium difficile infection (CDI) show the resistance to fecal microbiota transplantation (FMT), with the underlying mechanisms remaining elusive. Deciphering the intricate microbiome profile within this particular subset of FMT-refractory p …
·pubmed.ncbi.nlm.nih.gov·
Depletion of butyrate-producing microbes of the Firmicutes predicts nonresponse to FMT therapy in patients with recurrent Clostridium difficile infection - PubMed
Fecal microbiota transplantation in patients with metabolic syndrome and obesity: A randomized controlled trial - PubMed
Fecal microbiota transplantation in patients with metabolic syndrome and obesity: A randomized controlled trial - PubMed
There were no significant differences in biochemical or anthropometric parameters, between the two groups evaluated. Nevertheless, there were significant postprocedural differences in the microbiota composition between the placebo group. To date, clinical outcomes related to FMT remain uncertain.
·pubmed.ncbi.nlm.nih.gov·
Fecal microbiota transplantation in patients with metabolic syndrome and obesity: A randomized controlled trial - PubMed
Effectiveness of Fecal Microbiota Transplantation Treatment in Patients with Recurrent Clostridium Difficile Infection, Ulcerative Colitis, and Crohn's Disease: A Systematic Review
Effectiveness of Fecal Microbiota Transplantation Treatment in Patients with Recurrent Clostridium Difficile Infection, Ulcerative Colitis, and Crohn's Disease: A Systematic Review
Cronh’s disease and ulcerative colitis (UC) are diseases with unknown etiologies that cause ongoing inflammation in the gastrointestinal system. Chron's disease causes immunological dysregulation, and UC causes intestinal harm due to immune reactions. According to our study, fecal microbiota transplantation (FMT) has many benefits in the treatment of inflammatory bowel disease (IBD) by restoring intestinal homeostasis and reducing clinical symptoms. In mildly symptomatic patients with UC, an FMT treatment combined with an anti-inflammatory diet can produce remission, which would then be followed by a diet that maintained the anti-inflammatory effects. The efficacy of FMT consists of preventing flares or the consequences of IBD. As a result, we must emphasize that more investigation should be done before developing a therapeutic procedure for FMT in IBD and its associated consequences.
·cureus.com·
Effectiveness of Fecal Microbiota Transplantation Treatment in Patients with Recurrent Clostridium Difficile Infection, Ulcerative Colitis, and Crohn's Disease: A Systematic Review
Alexander Link on Twitter
Alexander Link on Twitter
Summary of our recent analysis on fecal microbiota transplantation (#FMT) in Germany✅FMT via colonoscopy remains one of the most common procedures for recurrent C. difficile infection.✅From 2015 to 2021 = 1645 FMT procedures were "performed/coded" in Germany✅ Due to… pic.twitter.com/pBX9bWUx24— Alexander Link (@alinkmd) July 14, 2023
·twitter.com·
Alexander Link on Twitter
Fecal microbiota transplantation for recurrent Clostridioides difficile infection in frail and very old patients - PubMed
Fecal microbiota transplantation for recurrent Clostridioides difficile infection in frail and very old patients - PubMed
FMT is effective and safe in very old patients. Frailty and high comorbidity do not limit use of FMT in these patients. Frailty assessment has potential to better identify patients at higher risk of worse outcomes or for repeat treatment with FMT.
·pubmed.ncbi.nlm.nih.gov·
Fecal microbiota transplantation for recurrent Clostridioides difficile infection in frail and very old patients - PubMed